Characteristics and Reporting of Number Needed to Treat, Number Needed to Harm, and Absolute Risk Reduction in Controlled Clinical Trials, 2001-2019

被引：12

作者：

Elliott, Marissa H. ^{[1
]}

Skydel, Joshua J. ^{[2
]}

Dhruva, Sanket S. ^{[3
]}

Ross, Joseph S. ^{[4
]}

Wallach, Joshua D. ^{[5
]}

机构：

[1] Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA

[2] Tufts Univ, Sch Med, Boston, MA 02111 USA

[3] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA USA

[4] Yale Sch Med, Dept Internal Med, New Haven, CT USA

[5] Yale Sch Publ Hlth, Dept Environm Hlth Sci, 60 Coll St,4th Floor,Room 411, New Haven, CT 06510 USA

来源：

JAMA INTERNAL MEDICINE | 2021年 / 181卷 / 02期

关键词：

D O I：

10.1001/jamainternmed.2020.4799

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This cross-sectional study assesses the trends and characteristics of absolute measure reporting in highly cited medical journals from 2001 to 2019.

引用

页码：282 / 284

页数：3

共 50 条

[11] Number needed to treat and relative risk reduction [J].

Jain, BP .

ANNALS OF INTERNAL MEDICINE, 1998, 128 (01) :72-72

[12] Misleading StatisticsThe Problems Surrounding Number Needed to Treat and Number Needed to Harm [J].

Jane L. Hutton .

Pharmaceutical Medicine, 2010, 24 (3) :145-149

[13] Reduction in number to treat versus number needed to treat [J].

Zhang, Chenyang ;

Yin, Guosheng .

BMC MEDICAL RESEARCH METHODOLOGY, 2021, 21 (01)

[14] Reduction in number to treat versus number needed to treat [J].

Chenyang Zhang ;

Guosheng Yin .

BMC Medical Research Methodology, 21

[15] Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat [J].

Ringe, Johann D. ;

Doherty, John G. .

RHEUMATOLOGY INTERNATIONAL, 2010, 30 (07) :863-869

[16] NUMBER NEEDED TO TREAT - ABSOLUTE RISK REDUCTION MAY BE EASIER FOR PATIENTS TO UNDERSTAND [J].

NORTH, D .

BRITISH MEDICAL JOURNAL, 1995, 310 (6989) :1269-1269

[17] Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat [J].

Johann D. Ringe ;

John G. Doherty .

Rheumatology International, 2010, 30 :863-869

[18] Number Needed to Treat in Multiple Sclerosis Clinical Trials [J].

Okwuokenye M. ;

Zhang A. ;

Pace A. ;

Peace K.E. .

Neurology and Therapy, 2017, 6 (1) :1-9

[19] Communicating Risks Clearly: Absolute Risk and Number Needed to Treat [J].

Sainani, Kristin L. .

PM&R, 2012, 4 (03) :220-222

[20] Number-needed-to-treat and placebo-controlled trials [J].

de Craen, AJM ;

Vickers, AJ ;

Tijssen, JGP ;

Kleijnen, J .

LANCET, 1998, 351 (9099) :310-310

← 1 2 3 4 5 →